TY  - GEN
AU  - Hillner,B E
TI  - Potential evaluation of the incremental cost-effectiveness of paclitaxel in advanced non-small-cell lung cancer (Eastern Cooperative Oncology Group 5592)
SN  - 1052-6773
PY  - 1995///1214
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Clinical Trials, Phase III as Topic
KW  - economics
KW  - Cost-Benefit Analysis
KW  - Humans
KW  - Lung Neoplasms
KW  - Paclitaxel
KW  - administration & dosage
N1  - Publication Type: Journal Article
ER  -